Robecosam AG boosted its stake in shares of Livent Corporation (NASDAQ:LTHM) by 38.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,320,000 shares of the company’s stock after acquiring an additional 366,287 shares during the quarter. Robecosam AG owned 0.90% of Livent worth $9,306,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in the business. Exane Derivatives acquired a new stake in shares of Livent in the first quarter valued at $32,000. First Mercantile Trust Co. acquired a new stake in shares of Livent in the first quarter valued at $33,000. Synovus Financial Corp acquired a new stake in shares of Livent in the first quarter valued at $39,000. Shell Asset Management Co. acquired a new stake in shares of Livent in the first quarter valued at $40,000. Finally, Live Your Vision LLC acquired a new stake in shares of Livent in the first quarter valued at $46,000.

Livent stock traded down $0.13 during mid-day trading on Tuesday, hitting $6.64. The stock had a trading volume of 31,734 shares, compared to its average volume of 2,690,018. The firm’s 50-day moving average is $6.85. Livent Corporation has a 12 month low of $5.49 and a 12 month high of $19.90.

Livent (NASDAQ:LTHM) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $0.12 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.12. The firm had revenue of $114.00 million during the quarter, compared to the consensus estimate of $108.85 million. The company’s revenue for the quarter was up 5.7% compared to the same quarter last year.

A number of brokerages have recently weighed in on LTHM. Nomura set a $9.00 target price on Livent and gave the company a “hold” rating in a research note on Wednesday, August 7th. Zacks Investment Research upgraded Livent from a “sell” rating to a “hold” rating in a research note on Wednesday, July 17th. Bank of America lowered Livent from a “neutral” rating to an “underperform” rating and lowered their target price for the company from $10.00 to $7.00 in a research note on Monday. Loop Capital lowered their target price on Livent to $12.00 and set a “buy” rating for the company in a research note on Thursday, May 9th. Finally, Argus lowered Livent from a “buy” rating to a “hold” rating and set a $7.58 target price for the company. in a research note on Thursday, May 16th. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and six have assigned a buy rating to the company’s stock. Livent presently has an average rating of “Hold” and a consensus price target of $15.11.

Livent Profile

Livent Corporation manufactures and sells performance lithium compounds that are used primarily in energy storage, specialty polymers, and chemical synthesis application. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and supplies butyllithium, which is used as a synthesizer in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in the production of lightweight materials for aerospace applications and non-rechargeable batteries.

Read More: What are popular green investing opportunities?

Institutional Ownership by Quarter for Livent (NASDAQ:LTHM)

Receive News & Ratings for Livent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livent and related companies with MarketBeat.com's FREE daily email newsletter.